{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T14:20:24Z","timestamp":1791469224951,"version":"4.3.4"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T00:00:00Z","timestamp":1639440000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.thromres.2021.12.006","type":"journal-article","created":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T08:23:30Z","timestamp":1653553410000},"page":"S72-S76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"S1","title":["COVID-19 associated coagulopathy and thrombosis in cancer"],"prefix":"10.1016","volume":"213","author":[{"given":"Marcel","family":"Levi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"van Es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.thromres.2021.12.006_bb0005","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.bja.2020.06.013","article-title":"COVID-19: a complex multisystem disorder","volume":"125","author":"Roberts","year":"2020","journal-title":"Br. J. Anaesth."},{"issue":"8","key":"10.1016\/j.thromres.2021.12.006_bb0010","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1001\/jama.2020.12839","article-title":"Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review","volume":"324","author":"Wiersinga","year":"2020","journal-title":"JAMA"},{"issue":"10229","key":"10.1016\/j.thromres.2021.12.006_bb0015","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.thromres.2021.12.006_bb0020","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2021.12.006_bb0025","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","article-title":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb. Res."},{"issue":"12","key":"10.1016\/j.thromres.2021.12.006_bb0030","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1182\/blood.2020005819","article-title":"Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysis","volume":"136","author":"Mulder","year":"2020","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.thromres.2021.12.006_bb0035","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1182\/bloodadvances.2020002197","article-title":"COVID-19 coagulopathy vs disseminated intravascular coagulation","volume":"4","author":"Levi","year":"2020","journal-title":"Blood Adv."},{"issue":"2","key":"10.1016\/j.thromres.2021.12.006_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10020191","article-title":"Proposal of the definition for COVID-19-associated coagulopathy","volume":"10","author":"Iba","year":"2021","journal-title":"J. Clin. Med."},{"issue":"6","key":"10.1016\/j.thromres.2021.12.006_bb0045","doi-asserted-by":"crossref","first-page":"e438","DOI":"10.1016\/S2352-3026(20)30145-9","article-title":"Coagulation abnormalities and thrombosis in patients with COVID-19","volume":"7","author":"Levi","year":"2020","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.thromres.2021.12.006_bb0050","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.thromres.2021.12.006_bb0055","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1055\/s-0040-1709498","article-title":"Recommendations for minimal laboratory testing panels in patients with COVID-19: potential for prognostic monitoring","volume":"46","author":"Favaloro","year":"2020","journal-title":"Semin. Thromb. Hemost."},{"issue":"7","key":"10.1016\/j.thromres.2021.12.006_bb0060","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1055\/s-0040-1712156","article-title":"Coronavirus disease 2019 coagulopathy: disseminated intravascular coagulation and thrombotic microangiopathy-either, neither, or both","volume":"46","author":"Levi","year":"2020","journal-title":"Semin. Thromb. Hemost."},{"issue":"7","key":"10.1016\/j.thromres.2021.12.006_bb0065","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1111\/jth.14854","article-title":"The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome","volume":"18","author":"Ranucci","year":"2020","journal-title":"J. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2021.12.006_bb0070","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s11739-020-02601-y","article-title":"COVID-19 coagulopathy: is it disseminated intravascular coagulation?","volume":"16","author":"Levi","year":"2021","journal-title":"Intern. Emerg. Med."},{"issue":"4","key":"10.1016\/j.thromres.2021.12.006_bb0075","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00271-13","article-title":"Mechanisms of severe acute respiratory syndrome coronavirus-induced acute lung injury","volume":"6","author":"Gralinski","year":"2013","journal-title":"mBio"},{"issue":"4","key":"10.1016\/j.thromres.2021.12.006_bb0080","first-page":"260","article-title":"Elevated plasma tissue-type plasminogen activator (t-PA) and soluble thrombomodulin in patients suffering from severe acute respiratory syndrome (SARS) as a possible index for prognosis and treatment strategy","volume":"18","author":"Liu","year":"2005","journal-title":"Biomed. Environ. Sci."},{"issue":"11","key":"10.1016\/j.thromres.2021.12.006_bb0085","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.1172\/JCI141374","article-title":"Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis","volume":"130","author":"Skendros","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.thromres.2021.12.006_bb0090","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1182\/blood.2020007008","article-title":"Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome","volume":"136","author":"Middleton","year":"2020","journal-title":"Blood"},{"issue":"10234","key":"10.1016\/j.thromres.2021.12.006_bb0095","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.thromres.2021.12.006_bb0100","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1350","article-title":"Endothelial cells are not productively infected by SARS-CoV-2","volume":"10","author":"Schimmel","year":"2021","journal-title":"Clin. Transl. Immunol."},{"issue":"8","key":"10.1016\/j.thromres.2021.12.006_bb0105","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1111\/jth.15409","article-title":"ADAMTS13 regulation of VWF multimer distribution in severe COVID-19","volume":"19","author":"Ward","year":"2021","journal-title":"J. Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.thromres.2021.12.006_bb0110","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/jth.13953","article-title":"The role of ADAMTS-13 in the coagulopathy of sepsis","volume":"16","author":"Levi","year":"2018","journal-title":"J. Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.thromres.2021.12.006_bb0115","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.chest.2020.11.005","article-title":"Incidence of VTE and bleeding among hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis","volume":"159","author":"Jim\u00e9nez","year":"2021","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.thromres.2021.12.006_bb0120","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/jth.14929","article-title":"Scientific and standardization committee communication: clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19","volume":"18","author":"Spyropoulos","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2021.12.006_bb0125","article-title":"Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: a systematic review and meta-analysis","volume":"29","author":"Malas","year":"2020","journal-title":"EClinicalMedicine"},{"issue":"9","key":"10.1016\/j.thromres.2021.12.006_bb0130","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/jth.14975","article-title":"Coagulopathy in COVID-19","volume":"18","author":"Iba","year":"2020","journal-title":"J. Thromb. Haemost."},{"issue":"11","key":"10.1016\/j.thromres.2021.12.006_bb0135","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1038\/s41416-021-01324-x","article-title":"COVID-19 and cancer registries: learning from the first peak of the SARS-CoV-2 pandemic","volume":"124","author":"Lee","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.thromres.2021.12.006_bb0140","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1470-2045(20)30096-6","article-title":"Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China","volume":"21","author":"Liang","year":"2020","journal-title":"Lancet Oncol."},{"issue":"10","key":"10.1016\/j.thromres.2021.12.006_bb0145","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1158\/2159-8290.CD-20-0773","article-title":"Clinical portrait of the SARS-CoV-2 epidemic in european cancer patients","volume":"10","author":"Pinato","year":"2020","journal-title":"Cancer Discov."},{"issue":"12","key":"10.1016\/j.thromres.2021.12.006_bb0150","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1001\/jamaoncol.2021.4083","article-title":"COVID-19 and cancer: a review of the registry-based pandemic response","volume":"7","author":"Desai","year":"2021","journal-title":"JAMA Oncol."},{"issue":"7","key":"10.1016\/j.thromres.2021.12.006_bb0155","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S1470-2045(20)30314-4","article-title":"COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study","volume":"21","author":"Garassino","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.thromres.2021.12.006_bb0160","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejca.2020.09.027","article-title":"Dutch oncology COVID-19 consortium: outcome of COVID-19 in patients with cancer in a nationwide cohort study","volume":"141","author":"de Joode","year":"2020","journal-title":"Eur. J. Cancer"},{"issue":"10241","key":"10.1016\/j.thromres.2021.12.006_bb0165","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0140-6736(20)31187-9","article-title":"Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study","volume":"395","author":"Kuderer","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.thromres.2021.12.006_bb0170","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/jnci\/djaa168","article-title":"Clinical characteristics and outcomes of COVID-19-infected cancer patients: a systematic review and meta-analysis","volume":"113","author":"Zhang","year":"2021","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.thromres.2021.12.006_bb0175","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejca.2020.08.011","article-title":"Mortality in patients with cancer and coronavirus disease 2019: a systematic review and pooled analysis of 52 studies","volume":"139","author":"Saini","year":"2020","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.thromres.2021.12.006_bb0180","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1200\/GO.21.00072","article-title":"Mortality in cancer patients with COVID-19 who are admitted to an ICU or who have severe COVID-19: a systematic review and meta-analysis","volume":"7","author":"Nadkarni","year":"2021","journal-title":"JCO Glob. Oncol."},{"issue":"20","key":"10.1016\/j.thromres.2021.12.006_bb0185","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1200\/JCO.21.01074","article-title":"Outcomes of COVID-19 in patients with cancer: report from the national COVID cohort collaborative (N3C)","volume":"39","author":"Sharafeldin","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.thromres.2021.12.006_bb0190","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.716361","article-title":"Thromboinflammation supports complement activation in cancer patients with COVID-19","volume":"12","author":"Peerschke","year":"2021","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.thromres.2021.12.006_bb0195","first-page":"966","article-title":"Clinical characteristics, risk factors, and cardiac manifestations of cancer patients with COVID-19","volume":"131","author":"Huang","year":"2021"},{"issue":"4","key":"10.1016\/j.thromres.2021.12.006_bb0200","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/jth.15261","article-title":"Clinical characteristics and risk factors for symptomatic venous thromboembolism in hospitalized COVID-19 patients: a multicenter retrospective study","volume":"19","author":"Li","year":"2021","journal-title":"J. Thromb. Haemost."},{"issue":"10","key":"10.1016\/j.thromres.2021.12.006_bb0205","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1111\/jth.15463","article-title":"The CoVID-TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID-19","volume":"19","author":"Li","year":"2021","journal-title":"J. Thromb. Haemost."},{"issue":"9","key":"10.1016\/j.thromres.2021.12.006_bb0210","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1111\/jth.15018","article-title":"Incidence of thrombosis and hemorrhage in hospitalized cancer patients with COVID-19","volume":"18","author":"Patell","year":"2020","journal-title":"J. Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.thromres.2021.12.006_bb0215","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.11788","article-title":"Trends in venous thromboembolism anticoagulation in patients hospitalized with COVID-19","volume":"4","author":"Vaughn","year":"2021","journal-title":"JAMA Netw. Open"},{"issue":"9","key":"10.1016\/j.thromres.2021.12.006_bb0220","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJMoa2105911","article-title":"Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19","volume":"385","author":"Lawler","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.thromres.2021.12.006_bb0225","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa2103417","article-title":"Therapeutic anticoagulation with heparin in critically ill patients with Covid-19","volume":"385","author":"Goligher","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2021.12.006_bb0230","article-title":"Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial","volume":"375","author":"Sholzberg","year":"2021","journal-title":"BMJ"},{"issue":"16","key":"10.1016\/j.thromres.2021.12.006_bb0235","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1001\/jama.2021.4152","volume":"325","author":"Sadeghipour","year":"2021","journal-title":"JAMA"},{"issue":"10291","key":"10.1016\/j.thromres.2021.12.006_bb0240","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/S0140-6736(21)01203-4","article-title":"Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial","volume":"397","author":"Lopes","year":"2021","journal-title":"Lancet"},{"issue":"17","key":"10.1016\/j.thromres.2021.12.006_bb0245","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1001\/jama.2021.17272","article-title":"Effect of antithrombotic therapy on clinical outcomes in outpatients with clinically stable symptomatic COVID-19: the ACTIV-4B randomized clinical trial","volume":"326","author":"Connors","year":"2021","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.thromres.2021.12.006_bb0250","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11864-021-00903-7","article-title":"Cancer or COVID-19? A review of recommendations for COVID-19 vaccination in cancer patients","volume":"22","author":"Gundavda","year":"2021","journal-title":"Curr. Treat. Options in Oncol."},{"issue":"9","key":"10.1016\/j.thromres.2021.12.006_bb0255","article-title":"COVID-19 vaccines in cancer patients. Seropositivity and safety. Systematic review and meta-analysis","volume":"9","author":"Cavanna","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"4","key":"10.1016\/j.thromres.2021.12.006_bb0260","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/s41591-021-01240-w","article-title":"COVID-19 vaccination: the VOICE for patients with cancer","volume":"27","author":"van der Veldt","year":"2021","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.thromres.2021.12.006_bb0265","article-title":"SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19","volume":"9","author":"Kreuzberger","year":"2021"},{"issue":"21","key":"10.1016\/j.thromres.2021.12.006_bb0270","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1056\/NEJMoa2107934","article-title":"Early treatment for Covid-19 with SARS-CoV-2 neutralizing antibody sotrovimab","volume":"385","author":"Gupta","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2021.12.006_bb0275","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2108163","article-title":"REGEN-COV antibody combination and outcomes in outpatients with Covid-19","volume":"385","author":"Weinreich","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.thromres.2021.12.006_bb0280","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1001\/jamainternmed.2021.6203","article-title":"Efficacy and safety of therapeutic-dose heparin vs standard prophylactic or intermediate-dose heparins for thromboprophylaxis in high-risk hospitalized patients with COVID-19: the HEP-COVID randomized clinical trial","volume":"181","author":"Spyropoulos","year":"2021","journal-title":"JAMA Intern. Med."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938482100565X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938482100565X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:48:06Z","timestamp":1758736086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004938482100565X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":56,"alternative-id":["S004938482100565X"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2021.12.006","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 associated coagulopathy and thrombosis in cancer","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2021.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}